Zomedica Pharmaceuticals Corp.
Zomedica Pharmaceuticals Corp. (ZOM) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 87 transactions totaling $6.2M, demonstrating a bearish sentiment with -$5.0M in net insider flow. The most recent transaction on Sep 5, 2024 involved a purchase of 100,000 shares valued at $13.0K.
ZOM Insider Activity Summary
Who Is Buying ZOM Stock?
No significant insider buying has been recorded for ZOM in the recent period.
Who Is Selling ZOM Stock?
No significant insider selling has been recorded for ZOM in the recent period.
Is Zomedica Pharmaceuticals Corp. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ZOM is bearish with an Insider Alignment Score of 10/100 and a net flow of -$5.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ZOM Frequently Asked Questions
Understanding ZOM Insider Activity
Insider trading at Zomedica Pharmaceuticals Corp. (ZOM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading ZOM stock, having executed 87 transactions in the past 90 days. The most active insider is Robert Cohen (Executive), who has made 5 transactions totaling $3.8M.
Related Tools
Track Zomedica Pharmaceuticals Corp. Insider Activity
Get notified when executives and directors at ZOM file new Form 4 transactions